Description
Latin name
Puregon
Packaging
1 cartridge
Pharmacological action
Puregon – follicle-stimulating. Puregon makes up for FSH deficiency. Regulates the normal growth and maturation of follicles, the synthesis of sex steroid hormones.
Indications
Female infertility during anovulation (including polycystic ovary syndrome, refractory to clomiphene citrate) assisted reproduction programs, incl. in vitro fertilization (for the induction of superovulation).
Contraindications
Hypersensitivity, tumors of the ovaries, breast, uterus, pituitary or hypothalamus, primary ovarian failure, ovarian cysts or ovarian enlargement not associated with polycystic ovary syndrome, impaired anatomy of the genital organs or uterine fibroma, incompatible.
Use during pregnancy and lactation
Contraindicated in pregnancy. Lactating women should abandon breastfeeding.
Composition
1 cartridge contains:
Active ingredient: follitropina-beta 900 IU.
and in vitro fertilization – ectopic pregnancy.
Drug Interaction
Concomitant administration of Puregon and clomiphene may enhance ovarian response.
A higher dose of Puregon may be required after pituitary desensitization with GnRH agonists to achieve sufficient ovarian response.
Pharmaceutically incompatible with other medicines.
Overdose
There is no evidence of an acute overdose of Puregon. The use of FSH at high doses can lead to the development of ovarian hyperstimulation syndrome, the symptoms of which are described above.
Treatment: In the event of symptoms of unwanted hyperstimulation (not related to the induction of superovulation during in vitro fertilization), the administration of Puregon should be discontinued. In this case, measures should be taken to prevent pregnancy and to refuse the introduction of HG, which may aggravate the undesirable effects. Treatment should be performed to eliminate the symptoms of ovarian hyperstimulation syndrome.
Storage conditions
The drug should be stored in a dark place, out of reach of children at a temperature of 2 ° to 8 ° C, do not freeze.
Expiration
2 Year
Deystvuyuschee substances
Follytropyn beta
dosage form
dosage form
injection
